Gastroenterology
News, opinions and meeting coverage in gastroenterology.
鈥� Gastric cancer incidence was lower after adjusting for certain factors in post hoc analyses
Latest in Gastroenterology
Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1
Alternative designs needed, researchers caution
Only a minority of patients adhered to SUNTRAC screening recommendations
26% of patients receiving tulisokibart achieved clinical remission vs 1% with placebo
Only a minority of patients adhered to SUNTRAC screening recommendations
26% of patients receiving tulisokibart achieved clinical remission vs 1% with placebo
Gastroenterology Case Studies
Discordant test results complicate diagnosis of suspected C. difficile
Moral of the story: don't walk barefoot in the fields
Clinicians found CT scan to be best diagnostic tool
More in Gastroenterology
Data since approvals suggest benefits limited to subgroups with PD-L1 expression of at least 1%
Drugmaker none-too-pleased with agency's request for additional studies
Limited benefit seen in patients with established cirrhosis, however
Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS
Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis
Rule would streamline criteria for organ donation from donors with HIV to recipients with HIV
Clinicians should perform liver blood tests before and during Veozah treatment
In trials, guselkumab more than doubled remission rates versus placebo
Agency advisory panel to examine complicated efficacy data and liver safety concerns
Botox can help "no-burp syndrome" symptoms
Also in TTHealthWatch: beta-blockers after MI
Mucosal damage seen on upper endoscopy associated with 76% higher Parkinson's risk
PREDICT-UC trial found no benefit with intensified or accelerated regimens
No difference in overall survival with versus without bolus, less toxicity without
